Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
25 Years
65 Years
Female
Cervical Cancer
Trial Information
Molecular Markers in Cervical Cancer Screening in the Feasibility of the Mathematical Markov Model Analysis
1. To carry out large-scale prospective randomized controlled clinical study to evaluate
the "cytological molecular markers Detect + P16INK4A" methods of screening accuracy and
reliability, as well as the screening method of the biological effects.
2. Markov set up mathematical model of screening tests to quantify the inputs and the
evaluation proceeds. With a view to optimize and perfect a simple, convenient,
practical and efficient program of cervical cancer screening.
Inclusion Criteria:
- Married women aged 25 to 65-year-old with risk factors
- No tumor and pelvic radiation therapy history
- Non-pregnant women at present
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Principal Investigator
Hong B Cai, Doctor
Investigator Role:
Study Director
Investigator Affiliation:
gynecologic oncology department, Zhongnan Hospital of Wuhan University
Authority:
China: Ethics Committee
Study ID:
320.6740
NCT ID:
NCT00889902
Start Date:
April 2009
Completion Date:
July 2011
Related Keywords:
- Cervical Cancer
- Molecular Markers
- Cervical Cancer
- Screening
- Makov
- Uterine Cervical Neoplasms
Name | Location |
|---|
